The effect of recombinant interleukin-8 on eosinophils' and neutrophils' migration in vivo and in vitro

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 8, 2003, Pages 795-801

  Bochenska Marciniak M ^a   Kupczyk, Maciej ^a   Gorski P ^a   Kuna, P ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Allergic rhinitis; Chernotaxis; Eosinophils; Interleukin 8; Neutrophils

Indexed keywords

CHEMOATTRACTANT; COMPLEMENT COMPONENT C5A; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 5; MYELOPEROXIDASE; PLACEBO; RANTES; RECOMBINANT INTERLEUKIN 8;

ADULT; ALLERGY; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE MARKER; DOSE TIME EFFECT RELATION; EOSINOPHILIA; FEMALE; GRASS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NOSE MUCOSA; NOSE MUCUS; POLLEN ALLERGY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADMINISTRATION, INTRANASAL; ADULT; CELL COUNT; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; NASAL MUCOSA; NEUTROPHILS; PEROXIDASE; RECOMBINANT PROTEINS; RHINITIS, ALLERGIC, SEASONAL;

EID: 0042672587     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00178.x     Document Type: Article

References (25)

1. SCHALL TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991;3:165-183.
2. SCHALL TJ, BACON K. Chemokines, leukocyte traficking, and inflammation. Curr Opin Immunol 1994;6:865-873.
3. BAZZONI F, CASSATELLA MA, ROSSI F, et al. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide1/interleukin 8. J Exp Med 1991;173:771-774.
4. FAHY JV, KIM WK, LIU J, et al. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1999;95:843-852.
5. Louis R, LAU LCK, BRON AO, et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
6. PARK H, JUNG K, KIM H, et al. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy 1999;29:1395-1401.
7. DJEU JY, MATSUSHIMA K, OPPENHEIM JJ, et al. Functional activation of human neutrophils by recombinant monocyte derived neytrophil chemotactic factor/IL-8. J Immunol 1990;144:2205-2210.
8. KERNEN P, WYMANN MP, TSCHARNER VV, et al. Shape, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. J Clin Invest 1991;87:2012-2017.
9. PEVERI P, WALZ A, DEWALD B, BAGGIOLINI M. A novel neutrophil activating factor produced by human mononuclear phagocytes. J Exp Med 1988;167:1547-1559.
10. SCHREDER JM. The monocyte derived neutrophil activating peptide (NAP/interleukin 8) stimulate human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate. J Exp Med 1989;170:847-863.
11. DETMERS PA, LO SK, OLSEN-EGBERT E, et al. Neutrophil-activating protein1/interleukin 8 stimulates the binding of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990;171:1155-1162.
12. HUBER AR, KUNKEL SL, TODD RF, WEISS JS. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;243:99-102.
13. KUNA P, IYER M, SIMONE J, KAPLAN AP. Studies of the activation of human eosinophils by Rantes. Int Rev Allergol Clin Immunol 1995;1:4-11.
14. KUNA P, LAZAROVICH M, KAPLAN AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:104-112.
15. GREIFF L, PIPKORN U, ALKNER U, PERSSON CGA. The 'nasal pool' device applies controlled concentrationsof solutes on human nasal airway mucosa and samples its surface exudations/secretions. Clin Exp Allergy 1990;86:599-605.
16. GARTNER I. Separation of human eosinophils in density gradient of polyvinylpyrrolidone-coated silica gel (Percoll). Immunology 1980;40:133-138.
17. ERGER RA, CASALE TB. Interleukin 8 (IL-8) induces eosinophil migration through endothelial and epithelial barier. J Allergy Clin Immunol 1993;91:312.
18. ERGER RA, CASALE TB. Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol (Lung Cell Mol Physiol) 1995;268:L117-L122.
19. SUR S, CROTTY TB, KEPHART GM, et al. Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis 1993;148:713-719.
20. SKOLD CM, LIU X, UMINO T, et al. Human neutrophil elastase augments fibroblast-mediated contraction of released collagen gels. Am J Respir Crit Care Med 1999;159:1138-1146.
21. VRUGT B, DJUKANOVIC R, BRON A, et al. New insights into the pathogenesis of severe corticosteroid-dependent asthma. J Allergy Clin Immunol 1996;98:s22-s26.
22. JOSE PJ, GRIFFITHS-JOHNSON DA, COLLINS PD, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a quinea pig model of allergic airways inflammation. J Exp Med 1994;179:881-887.
23. SIM TC, REECE LM, HILSMEIER KA, et al. Secretion of chemokines and other cytokines in allergen-induced nasal response: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995;152:927-933.
24. SCHMEKEL B, KARLSSON SE, LINDEN M, et al. Myeloperoxydase in human lung lavage. I. A marker of local neutrophil activity. Inflammation 1990;14:447-454.
25. TAUBER E, HEROUY Y, GOETZ M, et al. Assessment of serum myeloperoxydase in children with bronchial asthma. Allergy 1999;54:177-182.